Pharmaceutical Intermediates
- • Analgesics (56)
- • Anesthetics (52)
- • Anti-Addiction Agents (8)
- • Antibacterials (117)
- • Anticonvulsants (20)
- • Antidementia Agents (23)
- • Antidepressants (35)
- • Antiemetics (24)
- • Antifungals (24)
- • Antigout Agents (9)
- • Anti-inflammatory Agents (28)
- • Antimigraine Agents (21)
- • Antineoplastics (427)
- • Antiparasitics (11)
- • Antiparkinson Agents (28)
- • Antipsychotics (54)
- • Antispasticity Agents (12)
- • Antivirals (146)
- • Anxiolytics (16)
- • Blood Glucose Regulators (105)
- • Blood Products (61)
- • Cardiovascular Agents (179)
- • CNS Agents (22)
- • Dental and Oral Agents (8)
- • Dermatological Agents (19)
- • Electrolytes (15)
- • Gastrointestinal Agents (62)
- • Genetic/Enzyme Disorder (12)
- • Genitourinary Agents (47)
- • Immunological Agents (36)
- • Metabolic Bone Disease (6)
- • Ophthalmic Agents (32)
- • Respiratory Tract (51)
- • Skeletal Muscle Relaxants (5)
- • Sleep Disorder Agents (28)
- • Oled Material Intermediate (333)
- • Heterocyclic Compound (9763)
- • Bulk Drug Intermediates (17716)
Related News
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
2026-06-30 -
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
2026-06-26 -
Hormuz Is Reopening, But Chemical Logistics May Take Months to Recover
2026-06-22 -
US Chemical Shutdown Wave Expands, PS Units Become the Hardest Hit Segment
2026-06-30 -
Another Major Coating Manufacturer Acquired by a Central SOE: BNBM Acquires SUNROAD Group for Over RMB 300 Million, Locks in Three-Year Performance Pledge
2026-06-29 -
EU mulls expanding tariff scope on Chinese chemicals, sector-wide measures in the pipeline
2026-06-23
Anti-Addiction Agents Intermediates
Anti-Addiction Agents
Oxazol-2-ylboronic acid
(891660-66-5)-
![buy OXAZOL-2-YLBORONIC ACID]( "OXAZOL-2-YLBORONIC ACID")
Industrial Grade / pharmaceutical grade / 99%
$1/MT EXW
-
![buy oxazol-2-ylboronicacid]( "oxazol-2-ylboronicacid")
Industrial Grade / 99.00%
-
![buy 1,3-oxazol-2-ylboronic acid]( "1,3-oxazol-2-ylboronic acid")
-
![buy oxazol-2-ylboronic acid]( "oxazol-2-ylboronic acid")
Request for quotation , get quotes from more suppliers.
More Information
Anti-addiction agents are substances used to help reduce dependence on addictive substances such as opioids, alcohol, nicotine, or other drugs. They are widely applied in pharmaceutical formulations, clinical treatments, and research studies to assist in safe and controlled withdrawal.
The mechanisms of action for anti-addiction agents vary by type:
• Opioid receptor antagonists block the effects of opioids, helping to reduce cravings and prevent relapse.
• Nicotine replacement agents deliver controlled doses of nicotine to reduce withdrawal symptoms in tobacco users.
• Alcohol deterrent agents interfere with alcohol metabolism, creating unpleasant effects to discourage consumption.
• Other receptor modulators regulate neurotransmitter activity to manage addiction-related behavior and cravings.
Factors to consider when selecting anti-addiction agents:
• Effectiveness in reducing dependence and managing withdrawal symptoms.
• Safety, including potential side effects, toxicity, and patient tolerance.
• Compatibility with other medications or active ingredients.
• Regulatory compliance to meet pharmaceutical and medical standards.
Common forms include tablets, capsules, powders, and injectable solutions, enabling versatile applications in pharmaceuticals, healthcare, and research.
Frequently Asked Questions
Anti-Addiction Agents are pharmacological compounds designed to help individuals reduce or cease dependence on addictive substances such as opioids, alcohol, or nicotine. These agents work by targeting specific neurotransmitter systems in the brain to alleviate withdrawal symptoms, reduce cravings, or block the rewarding effects of the substance. Common examples include methadone, buprenorphine, naltrexone, and acamprosate.
Anti-Addiction Agents support recovery by stabilizing brain chemistry, reducing withdrawal discomfort, and decreasing the reinforcing effects of addictive substances. For instance, opioid agonists like methadone prevent withdrawal without producing euphoria, while antagonists like naltrexone block opioid receptors to deter relapse. When combined with behavioral therapy and counseling, these medications significantly improve long-term recovery outcomes.
When sourcing Anti-Addiction Agents, consider the following:1. Regulatory compliance—ensure the supplier adheres to FDA, EMA, or other relevant pharmacopeial standards.2. Purity and documentation—request certificates of analysis (CoA) and GMP compliance records.3. Supplier reliability—including consistent batch quality, secure supply chain, and technical support.4. Intended application—verify that the compound meets specifications for either clinical formulation or preclinical research.
Yes, Anti-Addiction Agents are tailored to specific addictions:- Opioid use disorder: methadone, buprenorphine, naltrexone- Alcohol use disorder: naltrexone, acamprosate, disulfiram- Nicotine dependence: varenicline, bupropionEach agent works through distinct mechanisms—such as receptor agonism, antagonism, or modulation of dopamine pathways—to address the unique neurobiology of each addiction type.